Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beta cell reactivity defines disease-relevant pancreatic CD8 T cells in type 1 diabetes.

bioRxiv : the preprint server for biology·2026
Same author

Thymic alveolar type 2 epithelial mimetic cells revealed by RUNX1 deficiency.

Nature immunology·2026
Same author

Runx3 instructs Aire<sup>+</sup> mTEC development, TSA gene expression, and central tolerance.

Journal of autoimmunity·2026
Same author

Generation of Functional Patient-Specific Thymus Organoids From Human Pluripotent Stem Cells (hPSCs) Using Air-Liquid Interface Culture.

Bio-protocol·2026
Same author

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

medRxiv : the preprint server for health sciences·2026
Same author

Beta cell-targeted PD-1 agonist inhibits cell-mediated autoimmunity in pancreas tissue slices.

Science advances·2026

Related Experiment Video

Updated: Aug 26, 2025

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

1.9K

Stem cell-based multi-tissue platforms to model human autoimmune diabetes.

Karla F Leavens1, Juan R Alvarez-Dominguez2, Linda T Vo3

  • 1Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania and Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Molecular Metabolism
|October 9, 2022
PubMed
Summary
This summary is machine-generated.

Human pluripotent stem cells (hPSCs) offer new models for studying type 1 diabetes (T1D). Combining hPSC-derived tissues, like pancreatic cells and immune cells, provides insights into T1D pathogenesis.

Keywords:
AutoimmunityDirect differentiationDisease modelingGenome engineeringPancreatic β cellsPluripotent stem cellsT cellsThymusType 1 diabetes

More Related Videos

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.0K
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
10:12

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

2.8K

Related Experiment Videos

Last Updated: Aug 26, 2025

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

1.9K
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.0K
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
10:12

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

2.8K

Area of Science:

  • Stem cell biology
  • Immunology
  • Endocrinology

Background:

  • Type 1 diabetes (T1D) is an autoimmune disease targeting insulin-producing pancreatic beta cells.
  • Current understanding of T1D initiation and progression is limited by the lack of suitable human disease models.
  • Human pluripotent stem cells (hPSCs) offer a promising avenue for developing more complex and relevant T1D models.

Purpose of the Study:

  • To review current hPSC differentiation methods for generating T1D-relevant cell types.
  • To discuss the application and limitations of hPSC-derived cells in T1D disease modeling.
  • To explore optimized platforms combining multiple cell types for human T1D modeling.

Main Methods:

  • Summarizing hPSC differentiation protocols for pancreatic islet cells, T cells, and thymic epithelium.
  • Reviewing existing applications and limitations of hPSC-derived cells in T1D modeling.
  • Discussing strategies for creating multi-cellular platforms for T1D research.

Main Results:

  • Advances in iPSC generation and genome engineering facilitate accurate disease modeling.
  • hPSC differentiation protocols are improving for key cell types involved in T1D.
  • Combined hPSC-derived beta cells and immune cells are yielding initial insights into T1D interactions.

Conclusions:

  • While challenges persist, hPSC-derived cells are a viable approach for modeling human T1D.
  • Combining multiple hPSC-derived tissues holds significant potential for novel insights into T1D etiology and pathogenesis.
  • Further optimization of platforms and differentiation protocols is crucial for advancing T1D research.